Introduction {#S1}
============

Spermatogenesis is a process to generate spermatozoa, composed of meiosis and spermiogenesis ([@B1], [@B2]). In meiosis, some population of spermatogonia differentiate into spermatids, and the spermatids change their shapes to become spermatozoa through spermiogenesis. This process is controlled by the hypothalamus--pituitary--gonadal axis. The pituitary secretes gonadotropin in response to gonadotropin releasing hormone from hypothalamus, by which steroid production is stimulated in testis, leading to normal progression of spermatogenesis ([@B3]--[@B5]). In addition, many testis-specific genes are activated in germ cells during meiosis and play important roles in spermatogenesis ([@B6]--[@B14]). However, the regulatory mechanism of spermatogenesis is not fully understood. To date, various long non-coding RNAs (lncRNAs) have been identified in the testis ([@B15], [@B16]), and some of them were shown to be upregulated by sex steroids ([@B17]--[@B21]). These findings suggest that lncRNAs are involved in the regulation of spermatogenesis. Nevertheless, the physiological significance of lncRNAs and the molecular mechanisms of their actions in the testis are largely unknown.

Long non-coding RNAs are molecules that are longer than 200 nucleotides and function without being translated ([@B22]). They are localized in nuclei, cytosols, and extracellular vesicles ([@B23]--[@B25]), and involved in various biological events such as development ([@B26], [@B27]), cell differentiation ([@B28], [@B29]), immune response ([@B30], [@B31]), and cell metabolism ([@B32], [@B33]). lncRNAs exert their effects *via* controlling gene expression at various levels, i.e., transcription, mRNA stability, and translation ([@B22], [@B26], [@B34]). In nuclei, lncRNAs are frequently involved in the transcriptional control of protein-coding genes ([@B35]). Thus, lncRNAs are presumed to be essential for transcriptional regulation of meiotic genes during spermatogenesis, while biological functions of testicular lncRNAs have not been well investigated.

We have studied the mechanism of gene activation during meiosis by using the mouse *testicular cell adhesion molecule 1* (*Tcam1*) locus as a model. The *Tcam1* gene is specifically expressed in spermatocytes and encodes a cell adhesion molecule, which is dispensable for sperm generation ([@B36], [@B37]). We previously identified a dual promoter--enhancer, which enhanced the *Tcam1* gene transcription and drove the *SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily d, member 2* (*Smarcd2*) gene and *lncRNA-Tcam1* ([@B38]). *lncRNA-Tcam1* was a novel testis-specific lncRNA which was 2.4-kb nucleotide long and localized to nuclei of germ cells but not to Leydig and Sertoli cells ([@B38]). Such germ cell-specific localization suggests that *lncRNA-Tcam1* plays a role in specific gene activation during meiosis.

To study molecular mechanisms in various types of cells, the *in vitro* cell culture system is useful, and some cell lines were established from male germ cells ([@B39]). The GC-2spd(ts) cell line was established from mouse spermatocytes using the SV40 large T antigen and the temperature-sensitive P53 mutant gene ([@B40]), and was widely used due to their ability of differentiation. After multiple cell passages, the cells still maintain some properties as male germ cells and are widely used for examining mechanisms in germ cells ([@B41]--[@B48]). Thus, the GC-2spd(ts) cell line is one of the most useful models for the study of the regulatory mechanism in male germ cells.

In this paper, we show that *lncRNA-Tcam1* induces immune-related genes in GC-2spd(ts) cells, which shed new light on novel regulatory roles of lncRNAs in the testis.

Materials and Methods {#S2}
=====================

Animals {#S2-1}
-------

The mice (C57/BL6) were maintained at 25°C with a photoperiod of 14:10 h light:dark with free access to food and water. Testes were isolated from 7- to 56-day-old mice and stored at −80°C until use. Experimental procedures used in this study were approved by the Institutional Animal Use and Care Committee at Hokkaido University.

Cell Culture {#S2-2}
------------

GC-2spd(ts) and its derivatives were cultured in Dulbecco Modified Eagle medium containing 10% fetal bovine serum, 100 U/ml penicillin, 100 μg/ml streptomycin, and 292 μg/ml [l]{.smallcaps}-glutamine (Invitrogen, Carlsbad, CA, USA) ([@B38], [@B40]). We used two types of GC-2spd(ts)-derived cell clones: lncRNA-6.9kb-EGFP clones that contained the intact sequence of the *lncRNA-Tcam1* locus (full sequence) and ΔCNS1-lncRNA-EGFP clones that lacked the *lncRNA-Tcam1* promoter (Δpromoter) (Figure [1](#F1){ref-type="fig"}A).

![A strategy to identify potential target genes of *long non-coding RNA-testicular cell adhesion molecule 1* (*lncRNA-Tcam1*). **(A)** Constructs used for establishing GC-2spd(ts) cell clones that expressed *lncRNA-Tcam1* at different levels. A 6.9-kb sequence encompassing the upstream and downstream regions of *lncRNA-Tcam1* was obtained from a mouse BAC clone, and connected to the enhanced green fluorescent protein (EGFP) gene (full sequence). A 0.8-kb sequence corresponding to the *lncRNA-Tcam1* promoter was deleted by restriction digestion (Δpromoter). The reporter EGFP gene was used to investigate the transcriptional regulation activity of the lncRNA promoter sequence in our previous study. Each construct was transfected into GC-2spd(ts) cells, and stable cell clones were established by the limited dilution method. **(B)** Expression of *lncRNA-Tcam1* in GC-2spd-Full and GC-2spd-Δprom. GC-2spd-Δprom was derived from the cells transfected with "Δpromoter" and used as a clone expressing *lncRNA-Tcam1* at a low level. GC-2spd-Full was a stably transfected clone with "full sequence" and used as the cells expressing *lncRNA-Tcam1* at a high level. Total RNA was isolated from each clone, and the expression level of *lncRNA-Tcam1* was measured by quantitative reverse transcription-polymerase chain reaction (qRT-PCR). The value was normalized to the *Gapdh* mRNA level, and the level in GC-2spd-Δprom was set to 1.0. The data are presented as mean value ± SD from three independent experiments. **(C)** An outline of the screening process to identify potential target genes of *lncRNA-Tcam1* in this study.](fendo-08-00299-g001){#F1}

RNA Preparation and Quantitative Reverse Transcription-Polymerase Chain Reaction (qRT-PCR) {#S2-3}
------------------------------------------------------------------------------------------

Isolation of total RNAs, treatment with DNase, and qRT-PCR were done as previously described ([@B38], [@B49]). To detect *lncRNA-Tcam1*, we used KOD SYBR qPCR Mix (Toyobo, Osaka, Japan), and the other transcripts were measured with Power SYBR Green Master Mix (Applied Biosystems, Foster City, CA, USA). Primer pairs are listed in Table [1](#T1){ref-type="table"}.

###### 

Oligonucleotide primers used in this study.

  Designation    Forward                      Reverse
  -------------- ---------------------------- ------------------------------
  lncRNA-Tcam1   5′-GACTGTCTGGGCAGAGTGAA-3′   5′-GAACCCAAGCAAAGCTGTAAAC-3′
  Aip            5′-GAGGACGGGATCCAAAAGC-3′    5′-CTGTGCAGCGTCCGAAAGT-3′
  Gapdh          5′-TGCACCACCAACTGCTTAGC-3′   5′-GGCATGGACTGTGGTCATGAG-3′
  H19            5′-TGGGAAAAGTGAAAGAACAG-3′   5′-GTGTGATGGAGAGGACAGAA-3′
  Ren1           5′-ATCCTTTATCTCGGCTCCTA-3′   5′-ACCTGGCTACAGTTCACAAC-3′
  Igfbp5         5′-CTGACCCTCTACCTTCCTTT-3′   5′-TGAGCAGACTTTCTTGGTTT-3′
  Gpx7           5′-GTTCACCACCAGGGAAAC-3′     5′-GCAGGACTTCTACGACTTCA-3′
  Bmyc           5′-GACCACGACGGTGATAGCTT-3′   5′-TCCAGCTTGGAGACCAGCTT-3′
  Avpr1a         5′-AAGATCCGCACAGTGAAGAT-3′   5′-GTTCAAGGAAGCCAGTAACG-3′
  Iigp1          5′-AAGAGCACACCGAGGGCTAT-3′   5′-GCTGGAGGGCAAATCATTAT-3′
  Oas2           5′-CTACTGACCCAGATCCAGAA-3′   5′-TGGCACTTTCCAAGGCTGTA-3′
  Trim30a        5′-GGACAGGTTACTTCCTCCTT-3′   5′-GTCTCTTGGTTGGTATCTGA-3′
  Ifit3          5′-CCAGCAGCACAGAAACAGAT-3′   5′-GACATACTTCCTTCCCTGAA-3′
  Hoxd13         5′-GGAACAGCCAGGTGTACTGT-3′   5′-TCATTCTCCAGTTCTTTGAG-3′
  Tgtp2          5′-ATGGCTCTGTATGGTAGAAG-3′   5′-CAGAACTCCACACCTCATGT-3′
  Mx2            5′-TTCAAGGAACACCCTCATT-3′    5′-CTCTGCGGTCAGTCTCTCT-3′
  Fabp5          5′-ACGGGAAGGAGAGCACGATA-3′   5′-GCAGGTGGCATTGTTCAT-3′
  Ifi47          5′-GTGAGAAACAGACCCGGTAT-3′   5′-ATGCCTCCTGCCTTACTGAT-3′
  Enpp5          5′-CCTTGTTTCTGCCTCCTCTT-3′   5′-AGCCGAATGGCATAGAGTAG-3′
  Oas1g          5′-CCAGATGAGGATGGTGTAGA-3′   5′-TCAGGAGGTGGAGTTTGAT-3′
  Usp18          5′-CTCGGTGATACCAAGGAACA-3′   5′-ACCAAAGTCAGCCATCCCAA-3′
  Gbp3           5′-GGATTCTTGAGCAGATAGCA-3′   5′-ATACCCTTGGTTTCGGATT-3′
  Ifi44          5′-GGTTTGATGTGATTGGTTTC-3′   5′-CTGCCATTTATTCTGTGTGA-3′
  Ifit1          5′-GAGTTCTGCTCTGCTGAAAA-3′   5′-AGGAACTGGACCTGCTCTGA-3′

RNA-Sequencing (RNA-seq) Analysis {#S2-4}
---------------------------------

Total RNAs were isolated from a lncRNA-6.9kb-EGFP clone (full sequence) and a ΔCNS1-lncRNA-EGFP clone (Δpromoter) using ISOGEN II (Nippongene, Tokyo, Japan) according to the manufacturer's instruction. The RNAs were further purified by phenol/chloroform--isoamylalcohol extraction and ethanol precipitation, and treated with TurboDNase (Applied Biosystems). The quality of the RNA samples was evaluated using BioAnalyzer (Agilent Technologies, Palo Alto, CA, USA) with RNA6000 Nano Chip. A 500-ng aliquot of total RNA from each sample was used to construct cDNA libraries using TruSeq Stranded mRNA Sample preparation kit (Illumina, San Diego, CA, USA), according to the manufacturer's instructions. The resulting cDNA library was validated using BioAnalyzer with DNA1000 Chip and quantified using Cycleave PCR Quantification Kit (Takara Bio Inc., Otsu, Japan). 101-cycle of single-end sequencing was performed using HiSeq1500 (Illumina) in the rapid mode. Total reads were extracted with CASAVA v1.8.2 (Illumina). Then, PCR duplicates, adaptor sequences and low quality reads were removed from the extracted reads as follows. Briefly, if the first 10 bases of the two reads were identical and the entire reads exhibited \>90% similarity, the reads were considered PCR duplicates. Remaining reads were then aligned with Bowtie version 2.2.3 to the mouse genome, mm10, which was downloaded from UCSC (<https://genome.ucsc.edu/>). The expression level of each gene was calculated as gene-specific reads per million total reads (RPM).

Plasmid Construction {#S2-5}
--------------------

A PiggyBac-based plasmid for induction of *lncRNA-Tcam1* transcription was generated as follows. A full length of *lncRNA-Tcam1* was amplified by PCR with mouse genome DNA and KOD FX Neo (Toyobo) using a primer pair, 5′-CCGGAGGAGCGGGAGCGGAA-3′ and 5′-CACCGGAAAACAGCTTTAAT-3′. We used the genome DNA as a template because *lncRNA-Tcam1* contained no intron. The product was subcloned into a pBluescript II vector (Stratagene, La Jolla, CA, USA) at *Eco*RV site, and the resulting plasmid was checked by DNA sequencing method. This plasmid was digested with *Sal*I, blunted by T4 DNA polymerase (Takara), and further digested with *Not*I. The *lncRNA-Tcam1* fragment was purified and inserted into pPBhCMV\*1-cHA-pPA at the *Not*I/blunted *Xho*I site. The completed plasmid was checked by DNA sequencing and named pPBhCMV\*1-lncTcam1-pPA. All plasmids for establishing the Tet-off system were kindly gifted by Dr. Kazuhiro Murakami ([@B50]).

Establishment of the Tet-Off System and Induction of *lncRNA-Tcam1* Transcription {#S2-6}
---------------------------------------------------------------------------------

GC-2spd(ts) cells were co-transfected with pPBhCMV\*1-lncTcam1-pPA, pPBCAGtTA-IN, pPyCAG-PBase, and pKO-Select-Puro plasmids using GeneJuice transfection reagent (Merck, Darmstadt, Germany) and selected with 3 μg/ml puromycin for 14 days. The selected cells were kept in the presence of 1 μg/ml doxycycline (Dox). For inducing *lncRNA-Tcam1* transcription, the cells were spread onto 35-mm dishes, and Dox was removed on the next day.

Statistical Analysis {#S2-7}
--------------------

The results were expressed as means ± SD. The data were analyzed by one-way analysis of variance (ANOVA) followed by Dunnett's test (Figures [2](#F2){ref-type="fig"}A, and [3](#F3){ref-type="fig"}B,C) or by Student's *t*-test (Figures [2](#F2){ref-type="fig"}B,C, [3](#F3){ref-type="fig"}A, and [4](#F4){ref-type="fig"}B) using Microsoft Excel statistical analysis functions (Microsoft Corporation, Redmond, WA, USA).

![Expression of *long non-coding RNA-testicular cell adhesion molecule 1* (*lncRNA-Tcam1*) and its target gene candidates in postnatal testes. **(A)** *lncRNA-Tcam1* expression in mouse testes at various postnatal stages. Total RNAs were purified from whole testes of mice at indicated ages. Expression levels of *lncRNA-Tcam1* were measured by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) as in Figure [1](#F1){ref-type="fig"}B, and the data were normalized to the housekeeping *Aip* gene. The value at day 7 was set to 1.0. **(B)** Expression of five candidate genes that were presumed to be suppressed by *lncRNA-Tcam1* in testes of 7- and 14-day-old mice. qRT-PCR was performed, and the data were normalized to *Aip*. The level at day 7 was set to 1.0. Light gray bars represent expression levels at 7 days of age, and light black bars indicate those at 14 days. **(C)** Expression of 16 candidate genes that were presumed to be activated by *lncRNA-Tcam1*. qRT-PCR was performed and the data were normalized as in **(B)**. All experiments were performed four times with two different RNA sets from testes, and the averages ± SD are indicated. The statistical significance was analyzed by one-way analysis of variance followed by Dunnett's test in **(A)** and by Student's *t*-test in **(B,C)**. \**P* \< 0.05, \*\**P* \< 0.01 compared to day 7.](fendo-08-00299-g002){#F2}

![Expression of *lncRNA-testicular cell adhesion molecule 1* (*lncRNA-Tcam1*) and its target gene candidates in GC-2spd-Full and GC-2spd-Δprom different from those used for RNA-sequencing. **(A)** *lncRNA-Tcam1* expression in GC-2spd-Full and GC-2spd-Δprom. The expression level of *lncRNA-Tcam1* was measured by quantitative reverse transcription-polymerase chain reaction (qRT-PCR), and the data were normalized to *Gapdh*. The level in GC-2spd-Δprom was set to 1.0. The data are the means ± SD from three independent experiments, and the statistical significance was evaluated by Student's *t*-test. \*\**P* \< 0.01 compared to GC-2spd-Δprom. **(B)** Expression of five candidate genes that were presumed to be suppressed by *lncRNA-Tcam1* in GC-2spd(ts) cells without being transfected, GC-2spd-Δprom, and GC-2spd-Full. qRT-PCR was performed, and the data were normalized to *Gapdh*. The level in GC-2spd(ts) cells was set to 1.0. White bars represent the data from GC-2spd(ts) cells without transfection, and gray and black bars show the values from GC-2spd-Δprom and GC-2spd-Full, respectively. **(C)** Expression of 16 candidate genes that were presumed to be activated by *lncRNA-Tcam1*. qRT-PCR was performed, and the data were normalized to *Gapdh*. The data are presented as in **(B)**. The data for GC-2spd(ts) cells are the averages ± SD from four independent experiments, and the other data represent the means ± SD from three independent experiments. The statistical significance was evaluated by one-way analysis of variance followed by Dunnett's test in **(B,C)**. \**P* \< 0.05, \*\**P* \< 0.01 compared to GC-2spd(ts) cells without transfection.](fendo-08-00299-g003){#F3}

![Expression of target gene candidates in response to induction of *long non-coding RNA-Tcam1* (*lncRNA-Tcam1*) transcription by the Tet-off system. **(A)** Induction of *lncRNA-Tcam1* transcription by the Tet-off system. GC-2spd(ts) cells were transfected with the construct for *lncRNA-Tcam1* overexpression in response to the doxycycline (Dox) removal. After the selection of successfully transfected cells with puromycin, they were cultured in the presence (Dox+) or absence of Dox (Dox−) for 24 or 48 h. The cells were collected, and quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was performed to measure the *lncRNA-Tcam1* level using *Gapdh* as an internal control. The data represent the means ± SD from three independent experiments. A dramatic increase of *lncRNA-Tcam1* transcription was observed in the Dox− sample at 48 h after the induction. **(B)** Expression of candidate genes at 48 h after the induction. qRT-PCR was performed, and the data were normalized to *Gapdh*. The values from Dox− samples were further normalized to those from Dox+ samples and expressed as fold-increases. The data represents the means ± SD from five independent experiments. The statistical significance was analyzed by Student's *t*-test. \**P* \< 0.05, \*\**P* \< 0.01 compared to Dox+ samples.](fendo-08-00299-g004){#F4}

Results {#S3}
=======

RNA-seq with GC-2spd(ts) Cell Clones Expressing *lncRNA-Tcam1* at Different Levels {#S3-1}
----------------------------------------------------------------------------------

To identify potential target genes that were regulated by *lncRNA-Tcam1*, we used GC-2spd(ts) cell clones we established in a previous study ([@B38]). In these lines, we stably transfected a construct, which contained a 6.9-kb sequence encompassing the *Tcam1* promoter and the *lncRNA-Tcam1* region (full sequence) or the same sequence without the *lncRNA-Tcam1* promoter (Δpromoter), connected to the enhanced green fluorescent protein (EGFP) gene (Figure [1](#F1){ref-type="fig"}A). *lncRNA-Tcam1* was expressed at higher levels in the clones with "full sequence" than those with "Δpromoter" ([@B38]), and hereafter, we designated "GC-2spd-Full" and "GC-2spd-Δprom," respectively. We chose a representative cell clone from each cell line, and the GC-2spd-Full and GC-2spd-Δprom clones showed 63-fold difference in expression levels of *lncRNA-Tcam1* by qRT-PCR (Figure [1](#F1){ref-type="fig"}B). We expected that target genes of this lncRNA should be expressed at different levels between them.

To determine the genes that were differentially expressed between GC-2spd-Full and GC-2spd-Δprom, we performed the RNA-seq analysis. 101-cycle of single-end sequencing using HiSeq 1500 yielded 13,054,029 and 13,194,037 reads for GC-2spd-Full and GC-2spd-Δprom, respectively, and 92.25 and 90.23% each of which was mapped to the mouse genome (mm10). The resultant fastq files were deposited on NCBI SRA database (accession no. SRR5435658 and SRR5435659). Subsequently, we compared the gene expression levels between GC-2spd-Full and GC-2spd-Δprom, and picked protein-coding genes that were expressed at lower levels than 0.1-fold in GC-2spd-Full as candidate genes negatively regulated by *lncRNA-Tcam1*, and those expressed at higher levels than fivefold in GC-2spd-Full as positively regulated genes. We then selected the gene whose RPKM value was higher than 1.5 in GC-2spd-Δprom or GC-2spd-Full. As a result, 29 genes were chosen as candidates potentially suppressed by *lncRNA-Tcam1*, and 27 genes as those activated by the lncRNA. However, after this selection, we found that one potentially activated gene was not detected in GC-2spd-Full by qRT-PCR, and eliminated it from candidate genes. Consequently, a total of 55 genes (29 potentially suppressed and 26 activated genes, Tables [S1](#SM3){ref-type="supplementary-material"} and [S2](#SM4){ref-type="supplementary-material"} in Supplementary Material) were subject to further analysis. An outline of the screening of candidate genes is shown in Figure [1](#F1){ref-type="fig"}C.

Expression of Candidate Genes in Postnatal Testes {#S3-2}
-------------------------------------------------

The target genes should be expressed correlatively to *lncRNA-Tcam1* in the testis. We thus examined the expression of these potential target genes during postnatal testis development. We collected testes at 7--56 days after birth and measured the *lncRNA-Tcam1* level by qRT-PCR. The transcript of *lncRNA-Tcam1* was detected in all samples, and a significant increase was observed between day 7 and day 14 after birth (Figure [2](#F2){ref-type="fig"}A). The absence of *lncRNA-Tcam1* expression in somatic cells in the mouse testis ([@B38]) led to the presumption that the transcription of *lncRNA-Tcam1* is initiated in spermatogonia and increased in primary spermatocytes. Then, we examined expression levels of the 55 candidate genes (29 potentially downregulated and 26 upregulated) in the testis at 7 days and 14 days after birth by qRT-PCR, to compare their levels in spermatogonia and primary spermatocytes. Among the genes that might be suppressed by *lncRNA-Tcam1*, 5 genes showed significant decreases during this period (Figure [2](#F2){ref-type="fig"}B), and 16 genes out of potentially activated candidates exhibited significant increases (Figure [2](#F2){ref-type="fig"}C). The expression patterns of genes that were not correlated with *lncRNA-Tcam1* is presented in Figures [S1](#SM1){ref-type="supplementary-material"} and [S2](#SM2){ref-type="supplementary-material"} in Supplementary Material. Signals for four downregulated candidates, *Cyclin D2* (*Ccnd2*), *CD55 molecule, decay accelerating factor for complement* (*Cd55*), *Syndecan 3* (*Sdc3*), and uc009oek.1, and an upregulated candidate, *2′-5*′ *oligoadenylate synthetase 3* (*Oas3*), were not detected by this analysis. From these data, 21 genes (5 genes down and 16 genes up) correlated with *in vivo lncRNA-Tcam1* expression were forwarded to the next analysis as target gene candidates.

Expression of Candidate Genes in GC-2spd(ts) Cell Clones Different from Those Used for RNA-seq {#S3-3}
----------------------------------------------------------------------------------------------

To further validate the RNA-seq and postnatal testis data, the expression was also examined using GC-2spd(ts) clones that were different from those used for RNA-seq. This would help us to select the real targets, because the properties might be different between cell clones as a result of the process to establish stable cells and pick the clones. qRT-PCR demonstrated that *lncRNA-Tcam1* was expressed at a 3.5-fold higher level in GC-2spd-Full than in GC-2spd-Δprom (Figure [3](#F3){ref-type="fig"}A). We assessed the expression of 21 candidate genes using these two clones and GC-2spd(ts) cells without being transfected. By comparing to cells without being transfected, false-positive genes (due to the establishment of cell clones) could be excluded. Among five genes potentially suppressed by *lncRNA-Tcam1, H19, imprinted maternally expressed transcript* (*H19*), *Insulin-like growth factor binding protein 5* (*Igfbp5*), and *Brain expressed myelocytomatosis oncogene* (*Bmyc*) were expressed at much higher levels in GC-2spd-Δprom than in GC-2spd-Full, but they were expressed at very low levels in GC-2spd(ts) cells without transfection (Figure [3](#F3){ref-type="fig"}B), indicating that these three genes were artifacts. Expression of *Renin 1 structural* (*Ren1*) and *Glutathione peroxidase 7* (*Gpx7*) genes was positively correlated with *lncRNA-Tcam1* (Figure [3](#F3){ref-type="fig"}B), which was inconsistent with the genes suppressed by *lncRNA-Tcam1*. Therefore, the five genes were unlikely to be targets of *lncRNA-Tcam1*.

Among 16 genes, expression levels of five genes \[*2′-5*′ *oligoadenylate synthetase 2* (*Oas2*), *Homeobox D13* (*Hoxd13*), *MX dynamin-like GTPase 2* (*Mx2*), *Fatty acid binding protein 5, epidermal* (*Fabp5*), and *Interferon-induced protein wit tetratricopeptide repeats 1* (*Ifit1*)\] were not significantly higher in GC-2spd-Full than in GC-2spd(ts) cells (Figure [3](#F3){ref-type="fig"}C), excluding the possibility that these genes were targets of *lncRNA-Tcam1*. On the other hand, 11 genes were expressed at significantly higher levels in GC-2spd-Full than in GC-2spd(ts) cells, and their expression was higher in GC-2spd-Full than in GC-2spd-Δprom (Figure [3](#F3){ref-type="fig"}C). Collectively, these expression profiles detected 11 potential genes upregulated by *lncRNA-Tcam1* and they were subjected to further analysis.

Identification of Genes Upregulated by *lncRNA-Tcam1* {#S3-4}
-----------------------------------------------------

We finally examined whether *lncRNA-Tcam1* could activate the 11 candidate genes in the Tet-off system. We constructed the plasmid in which the hCMV\*1 promoter induced *lncRNA-Tcam1* transcription in response to the Dox removal, and stably transfected GC-2spd(ts) cells with it. qRT-PCR of the stable transfectants confirmed that the expression of *lncRNA-Tcam1* was 57-fold induced exclusively at 48 h after removal of Dox (Figure [4](#F4){ref-type="fig"}A).

We examined expression levels of the 11 candidate genes 48 h after the Dox removal by qRT-PCR. We set the value from the control cells that were cultured for 48 h with Dox to 1.0 and calculated the levels of candidates. six genes, *Tripartite motif-containing 30A* (*Trim30a*), *Interferon-induced protein wit tetratricopeptide repeats 3* (*Ifit3*), *T cell-specific GTPase 2* (*Tgtp2*), *Interferon gamma inducible protein 47* (*Ifi47*), *2′-5*′ *oligoadenylate synthetase 1G* (*Oas1g*), and *Guanylate binding protein 3* (*Gbp3*), exhibited significantly higher expression in the cells without Dox, and their fold-increases were 1.46, 3.37, 2.43, 1.44, 1.49, and 1.69, respectively (Figure [4](#F4){ref-type="fig"}B). We confirmed significant levels of expression of the six genes in the germ cell fraction from adult mouse testes (Table [S3](#SM5){ref-type="supplementary-material"} in Supplementary Material). Interestingly, five genes of the final six candidates, namely, *Ifit3, Tgtp2, Ifi47, Oas1g*, and *Gbp3*, were immune response genes, and *Trim30a* was a negative-feedback regulator of immune response (Table [2](#T2){ref-type="table"}). Collectively, these data indicated that *lncRNA-Tcam1* is responsible for the regulation of some immune response pathways during spermatogenesis.

###### 

Genes potentially activated by *lncRNA-Tcam1*.

  Gene      UCSC-ID      Description                                                   Relation to immune response   Chromosome
  --------- ------------ ------------------------------------------------------------- ----------------------------- ------------
  Trim30a   uc009iwh.1   Tripartite motif-containing 30A                               Negative-feedback regulator   7
  Ifit3     uc008hgo.1   Interferon-induced protein with tetratricopeptide repeats 3   Immune response gene          19
  Tgtp2     uc007ipp.2   T cell-specific GTPase 2                                      Immune response gene          11
  Ifi47     uc007ipq.1   Interferon gamma inducible protein 47                         Immune response gene          11
  Oas1g     uc008zii.1   2′-5′ oligoadenylate synthetase 1G                            Immune response gene          5
  Gbp3      uc008rov.1   Guanylate binding protein 3                                   Immune response gene          3

Discussion {#S4}
==========

Among various mouse and human tissues, the testis contains large numbers of lncRNAs ([@B15], [@B16]), as evidenced by recent transcriptomic analyses identifying many lncRNAs in different postnatal testes or fractionated germ cells ([@B51]--[@B53]). However, their functions in spermatogenesis are largely unknown in mammals, and we revealed the upregulation of gene expression of immune-related genes by mouse male germ cell-specific *lncRNA-Tcam1* using spermatocyte-derived GC-2spd(ts) cells as a model.

We performed RNA-seq of GC-2spd(ts) cell clones that expressed *lncRNA-Tcam1* at different levels and selected 55 genes as initial candidates of its targets. Then, we investigated (1) their expression in testes at different developmental stages, (2) their expression in GC-2spd(ts) clones different from those used for RNA-seq, and (3) the response to induction of *lncRNA-Tcam1* transcription by the Tet-off system. Eventually, these analyses detected six immune-related genes, *Trim30a, Ifit3, Tgtp2, Ifi47, Oas1g*, and *Gbp3* that were upregulated by *lncRNA-Tcam1*. Taken together, these results suggest that *lncRNA-Tcam1* participates in the functional regulation of the mouse testis *via* upregulation of the six genes during spermatogenesis.

In our previous study, we reported that *lncRNA-Tcam1* expression was unlikely to be related to the regulation of neighboring genes ([@B38]), and our present data support this. Four target genes, *Trim30a, Ifit3, Oas1g*, and *Gbp3*, were located on different chromosomes from *lncRNA-Tcam1*, and the other two genes, *Tgtp2* and *Ifi47*, were at the same locus on chromosome 11 but approximately 57 Mb distant from the lncRNA (Table [2](#T2){ref-type="table"}). Therefore, *lncRNA-Tcam1* does not control its neighboring genes. How this lncRNA activates the six genes is not clear, but the *lncRNA-Tcam1* locus may spatially locate at positions close to its target gene loci in nuclei of germ cells or the *lncRNA-Tcam1* transcript may bind to its target loci in response to immune signals. Additionally, the modes of action of *lncRNA-Tcam1* in recognition of and binding to targets may be similar to those of other lncRNAs related to immune response ([@B54], [@B55]). Such studies are currently in progress.

Of particular interest is that the five target genes were immune response genes. *Ifit3* and *Oas1g* have antiviral functions in some tissues including the lung and liver ([@B56], [@B57]), and *Tgtp2, Ifi47*, and *Gbp3* contributes to defense against bacteria and protozoa ([@B58]--[@B60]). Interestingly, *Ifi47* and *Gbp3* were reported to play some roles in defense against *Toxoplasma Gondii* ([@B58], [@B60]), which could impair spermatogenesis by infecting the rat testis ([@B61]). In addition, *Trim30a* is a negative-feedback regulator of immune response against virus ([@B62]). Although their functional roles in the testis remain unknown ([@B58], [@B60], [@B63]), these findings suggest that *lncRNA-Tcam1* participates in immune response to multiple pathogenic microbes by activating these genes during meiosis, and thereby contributes to normal progression of spermatogenesis regulated by the endocrine system.

The physiological significance of some of the target genes in immune defense has been demonstrated by several studies. Interleukin 17a was elevated by infection of rhinovirus in the lung, and led to upregulation of the *Oas1g* gene, which caused the degradation of viral RNAs ([@B64]). Dengue virus infection in lung epithelial cells upregulated the *Ifit3* gene, which suppressed the virus production ([@B65]). In dendritic cells, infection of *Listeria monocytogenes* increased expression of *Tgtp2* and *Oas1g* genes to eventually reduce the bacterial titer ([@B66]). All of these indicate that the genes are responsive to various types of infection and contribute to immune defense *in vivo*, which suggests that they also play important roles in the immune response in the testis.

The testis is an immunoprivileged tissue and has evolved the innate immune system ([@B67], [@B68]). The innate immunity involves the interferon response, and key molecules for that are Toll-like receptors (TLRs). Activation of TLRs induces the interferon production and increases expression of interferon-responsive genes ([@B67]). Because mouse spermatogonia and primary spermatocytes constitutively express one of the TLR genes, *Tlr3*, and interferon receptor genes ([@B69], [@B70]), TLR3-mediated immune pathway is likely to be active in the testis. Notably, the five immune responsive genes are known to be responsive to interferon, so they may be activated through the TLR3 pathway in germ cells when the testis is infected by some pathogens. Therefore, *lncRNA-Tcam1* may regulate some innate immune responses by controlling the interferon-responsive genes during meiosis.

It is now well known that a wide variety of lncRNAs are expressed in the testis ([@B15], [@B16], [@B71]), but their functional investigation has just begun. A few studies have thus far indicated biological roles of lncRNAs in self-renewal of spermatogonia ([@B72]), regulation of a signaling pathway ([@B73]), and progression of meiosis ([@B74]) during spermatogenesis. We originally revealed the involvement of a testis-specific lncRNA, *lncRNA-Tcam1*, in the regulation of immune-related genes in mouse spermatocyte-derived cells, and thus, the present study paves the way for investigating novel immune molecular mechanisms underpinning spermatogenesis *via* the endocrine system.
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###### 

Expression of target gene candidates downregulated by *lncRNA-Tcam1* in postnatal testes. Total RNAs were isolated from 7- and 14-day-old mouse testes, and quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was performed for the candidate genes that might be downregulated by *lncRNA-Tcam1*. All the data were normalized to the value of *Aip* gene. Gray and light black bars represent the data in 7- and 14-day-old testes, respectively. None of the indicated genes showed inverse correlation to *lncRNA-Tcam1*.

###### 

Click here for additional data file.

###### 

Expression of target gene candidates upregulated by *lncRNA-Tcam1* in postnatal testes. Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was performed, and the data are shown as in Supplemental Figure [S1](#SM1){ref-type="supplementary-material"}. None of the indicated genes exhibited positive correlation to *lncRNA-Tcam1*.
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Click here for additional data file.

###### 

Candidate genes initially identified as those suppressed by *lncRNA-Tcam1*. RNA-sequencing revealed 29 genes that were differentially expressed between GC-2spd-Full and GC-2spd-Δprom. UCSC IDs which mapped to the same gene symbol were unified.
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Click here for additional data file.

###### 

Candidate genes initially identified as those activated by *lncRNA-Tcam1*. RNA-sequencing revealed 26 genes that were differentially expressed between GC-2spd-Full and GC-2spd-Δprom. UCSC IDs which mapped to the same gene symbol were unified.
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Click here for additional data file.

###### 

Ct values of the six final candidate genes that were potentially activated by *lncRNA-Tcam1* in testicular germ cells by quantitative reverse transcription-polymerase chain reaction (qRT-PCR). The value of an internal control (*Aip*) is also indicated.

###### 

Click here for additional data file.
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